129 related articles for article (PubMed ID: 35673557)
1. Erratum: SDC2 and TFPI2 Methylation in Stool Samples as an Integrated Biomarker for Early Detection of Colorectal Cancer [Corrigendum].
Cancer Manag Res; 2022; 14():1845-1846. PubMed ID: 35673557
[TBL] [Abstract][Full Text] [Related]
2. SDC2 and TFPI2 Methylation in Stool Samples as an Integrated Biomarker for Early Detection of Colorectal Cancer.
Zhang W; Yang C; Wang S; Xiang Z; Dou R; Lin Z; Zheng J; Xiong B
Cancer Manag Res; 2021; 13():3601-3617. PubMed ID: 33958894
[TBL] [Abstract][Full Text] [Related]
3. Methylation of
Zhang L; Dong L; Lu C; Huang W; Yang C; Wang Q; Wang Q; Lei R; Sun R; Wan K; Li T; Sun F; Gan T; Lin J; Yin L
Front Mol Biosci; 2021; 8():706754. PubMed ID: 35004840
[No Abstract] [Full Text] [Related]
4. Feasibility of quantifying
Oh TJ; Oh HI; Seo YY; Jeong D; Kim C; Kang HW; Han YD; Chung HC; Kim NK; An S
Clin Epigenetics; 2017; 9():126. PubMed ID: 29225717
[TBL] [Abstract][Full Text] [Related]
5. Stool DNA Test of Methylated
Niu F; Wen J; Fu X; Li C; Zhao R; Wu S; Yu H; Liu X; Zhao X; Liu S; Wang X; Wang J; Zou H
Cancer Epidemiol Biomarkers Prev; 2017 Sep; 26(9):1411-1419. PubMed ID: 28619831
[No Abstract] [Full Text] [Related]
6. DNA methylation biomarkers in stool for early screening of colorectal cancer.
Chen J; Sun H; Tang W; Zhou L; Xie X; Qu Z; Chen M; Wang S; Yang T; Dai Y; Wang Y; Gao T; Zhou Q; Song Z; Liao M; Liu W
J Cancer; 2019; 10(21):5264-5271. PubMed ID: 31602277
[No Abstract] [Full Text] [Related]
7. Colorectal cancer screening using a stool DNA-based SDC2 methylation test: a multicenter, prospective trial.
Kim CW; Kim H; Kim HR; Kye BH; Kim HJ; Min BS; Oh TJ; An S; Lee SH
BMC Gastroenterol; 2021 Apr; 21(1):173. PubMed ID: 33858326
[TBL] [Abstract][Full Text] [Related]
8. Methylation of TFPI2 in stool DNA: a potential novel biomarker for the detection of colorectal cancer.
Glöckner SC; Dhir M; Yi JM; McGarvey KE; Van Neste L; Louwagie J; Chan TA; Kleeberger W; de Bruïne AP; Smits KM; Khalid-de Bakker CA; Jonkers DM; Stockbrügger RW; Meijer GA; Oort FA; Iacobuzio-Donahue C; Bierau K; Herman JG; Baylin SB; Van Engeland M; Schuebel KE; Ahuja N
Cancer Res; 2009 Jun; 69(11):4691-9. PubMed ID: 19435926
[TBL] [Abstract][Full Text] [Related]
9. The methylation of SDC2 and TFPI2 defined three methylator phenotypes of colorectal cancer.
Lei R; Zhao Y; Huang K; Wang Q; Wan K; Li T; Yang H; Lv X
BMC Gastroenterol; 2022 Feb; 22(1):88. PubMed ID: 35227195
[TBL] [Abstract][Full Text] [Related]
10. Early detection of colorectal cancer based on presence of methylated syndecan-2 (SDC2) in stool DNA.
Han YD; Oh TJ; Chung TH; Jang HW; Kim YN; An S; Kim NK
Clin Epigenetics; 2019 Mar; 11(1):51. PubMed ID: 30876480
[TBL] [Abstract][Full Text] [Related]
11. The Application Value of Syndecan-2 Gene Methylation for Colorectal Cancer Diagnosis: A Clinical Study and Meta-Analyses.
Yue C; Zhang Y; Wang Y; Zhang Z; Zhang M; Wang H; Chen W; Shang Z; Xin Y; Zhang X; Zhang Y
Front Med (Lausanne); 2022; 9():753545. PubMed ID: 35372441
[TBL] [Abstract][Full Text] [Related]
12. Hypermethylated DNA as a biomarker for colorectal cancer: a systematic review.
Rasmussen SL; Krarup HB; Sunesen KG; Pedersen IS; Madsen PH; Thorlacius-Ussing O
Colorectal Dis; 2016 Jun; 18(6):549-61. PubMed ID: 26998585
[TBL] [Abstract][Full Text] [Related]
13. A Novel Stool Methylation Test for the Non-Invasive Screening of Gastric and Colorectal Cancer.
Ma L; Gong J; Zhao M; Kong X; Gao P; Jiang Y; Liu Y; Feng X; Si S; Cao Y
Front Oncol; 2022; 12():860701. PubMed ID: 35419280
[TBL] [Abstract][Full Text] [Related]
14. Methylated
Zhao G; Liu X; Liu Y; Ma Y; Yang J; Li H; Xiong S; Fei S; Zheng M; Zhao X
J Cancer; 2021; 12(9):2665-2672. PubMed ID: 33854626
[No Abstract] [Full Text] [Related]
15. Analysis of
Park YS; Kim DS; Cho SW; Park JW; Jeon SJ; Moon TJ; Kim SH; Son BK; Oh TJ; An S; Kim JH; Chae JD
Gut Liver; 2018 Sep; 12(5):508-515. PubMed ID: 29730903
[TBL] [Abstract][Full Text] [Related]
16. A systematic evaluation of stool DNA preparation protocols for colorectal cancer screening via analysis of DNA methylation biomarkers.
Jin S; Ye Q; Hong Y; Dai W; Zhang C; Liu W; Guo Y; Zhu D; Zhang Z; Chen S; Wang Y; Li D; Ma W; Yang Z; Li J; Zheng Z; Luan J; Wu X; Jiang F; Xu C; Ding C
Clin Chem Lab Med; 2020 Jul; 59(1):91-99. PubMed ID: 32673280
[TBL] [Abstract][Full Text] [Related]
17. Aberrant DNA Methylation of
Zhao G; Liu X; Liu Y; Li H; Ma Y; Li S; Zhu Y; Miao J; Xiong S; Fei S; Zheng M
Front Genet; 2020; 11():643. PubMed ID: 32625237
[TBL] [Abstract][Full Text] [Related]
18. [Human stool vimentin, oncostatin M receptor and tissue factor pathway inhibitor 2 gene methylation analysis for the detection of colorectal neoplasms].
Zhang JP; Wang J; Gui YL; Zhu QQ; Xu ZW; Li JS
Zhonghua Yi Xue Za Zhi; 2011 Sep; 91(35):2482-4. PubMed ID: 22321844
[TBL] [Abstract][Full Text] [Related]
19. Detection of TFPI2 methylation in the serum of gastric cancer patients.
Hibi K; Goto T; Shirahata A; Saito M; Kigawa G; Nemoto H; Sanada Y
Anticancer Res; 2011 Nov; 31(11):3835-8. PubMed ID: 22110206
[TBL] [Abstract][Full Text] [Related]
20. Erratum: Analysis of Mono-ADP-Ribosylation Levels in Human Colorectal Cancer [Corrigendum].
Cancer Manag Res; 2021; 13():4967. PubMed ID: 34188549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
